Costly eye drug and far cheaper alternative have similar side effects -study By: Reuters: Company News September 14, 2014 at 19:01 PM EDT * Avastin far cheaper but not officially approved for eyes Read More >> Related Stocks: Bay National Corp Regeneron Pharmaceuticals Rogers Corp